-
Loading metrics
Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab?
- Izabela Chmielewska,
- Marta Dudzińska,
- Michał Szczyrek,
- Joanna Świrska,
- Kamila Wojas-Krawczyk,
- Agnieszka Zwolak
x
- Published: September 29, 2021
- https://doi.org/10.1371/journal.pone.0257484